鶹ýӰ

Meeting Coverage

ASH Video Pearls: ALL

Video Pearls from the American Society of Hematology

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

Ponatinib-blinatumomab led to durable remissions without transplant in most, but 13% relapsed

image

Latest ASH Video Pearls: ALL Meeting Coverage

Advances in ALL at ASH Meeting Include New Blinatumomab Data and More

Researchers also examined MRD to guide treatment decisions, and other personalized approaches

December 18, 2024